Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017 Oct 11;18(1):769.
doi: 10.1186/s12864-017-4146-z.

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance

Affiliations

A multiple genome analysis of Mycobacterium tuberculosis reveals specific novel genes and mutations associated with pyrazinamide resistance

Patricia Sheen et al. BMC Genomics. .

Abstract

Background: Tuberculosis (TB) is a major global health problem and drug resistance compromises the efforts to control this disease. Pyrazinamide (PZA) is an important drug used in both first and second line treatment regimes. However, its complete mechanism of action and resistance remains unclear.

Results: We genotyped and sequenced the complete genomes of 68 M. tuberculosis strains isolated from unrelated TB patients in Peru. No clustering pattern of the strains was verified based on spoligotyping. We analyzed the association between PZA resistance with non-synonymous mutations and specific genes. We found mutations in pncA and novel genes significantly associated with PZA resistance in strains without pncA mutations. These included genes related to transportation of metal ions, pH regulation and immune system evasion.

Conclusions: These results suggest potential alternate mechanisms of PZA resistance that have not been found in other populations, supporting that the antibacterial activity of PZA may hit multiple targets.

Keywords: Drugs; Efflux pump; Genes; Genome; MDR; Metallochaperone; Mutations; Pyrazinamide; Resistance; Tuberculosis.

PubMed Disclaimer

Conflict of interest statement

Ethics approval and consent to participate

Ethical approval for samples collection and sequencing was obtained from the Institutional Ethics Committee of Universidad Peruana Cayetano Heredia and The London School of Hygiene and Tropical Medicine. Institutional approval was obtained from the Peruvian Ministry of Health. Written informed consent was obtained from all of the enrolled patients. The samples form part of a multi-center drug resistance study (pathogenseq.lshtm.ac.uk/gdrs).

Consent for publication

Not applicable.

Competing interests

The authors declare that they have no competing interests.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Figures

Fig. 1
Fig. 1
Distances-based tree based on spoligotyping profile of the strains
Fig. 2
Fig. 2
Histogram with standard errors of the strains in the study, according their SIT code. In black (PZA resistant strains), in white (PZA susceptible strains)

Similar articles

Cited by

References

    1. World Health Organization . Global Tuberculosis Report. 2016.
    1. East African/British Medical Research Councils Controlled clinical trial of short-course (6-month) regimens of chemotherapy for treatment of pulmonary tuberculosis. Lancet. 1972;299:1079–1085. doi: 10.1016/S0140-6736(72)91426-2. - DOI - PubMed
    1. Zhang Y, Scorpio A, Nikaido H, Sun Z. Role of acid pH and deficient efflux of pyrazinoic acid in unique susceptibility of mycobacterium tuberculosis to pyrazinamide. J Bacteriol. 1999;181:2044–2049. - PMC - PubMed
    1. Konno K, Feldmann FM, McDermott W. Pyrazinamide susceptibility and amidase activity of tubercle bacilli. Am Rev Respir Dis. 1967;95:461–469. - PubMed
    1. Zhang Y, Wade MM, Scorpio A, Zhang H, Sun Z. Mode of action of pyrazinamide: disruption of mycobacterium tuberculosis membrane transport and energetics by pyrazinoic acid. J Antimicrob Chemother. 2003;52:790–795. doi: 10.1093/jac/dkg446. - DOI - PubMed